Action 002437 HARBIN GLORIA PHARMACEUTICALS CO., LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Harbin Gloria Pharmaceuticals Co., Ltd

Actions

002437

CNE100000QG8

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 17/05/2024 		Varia. 5j. Varia. 1 janv.
2,12 CNY -0,47 % Graphique intraday de Harbin Gloria Pharmaceuticals Co., Ltd -1,40 % -15,54 %
26/04 HARBIN GLORIA PHARMACEUTICALS Co. déclare ses résultats pour le premier trimestre clos le 31 mars 2024 CI
12/04 HARBIN GLORIA PHARMACEUTICALS Co. LTD publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023
HARBIN GLORIA PHARMACEUTICALS Co., LTD completed the acquisition of additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd.
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023
HARBIN GLORIA PHARMACEUTICALS Co., LTD agreed to acquire additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd. for CNY 35 million.
HARBIN GLORIA PHARMACEUTICALS Co., LTD(XSEC:002437) added to S&P Global BMI Index
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023
Harbin Gloria Pharma Offloads Entire 42% Stake in Biotech Unit for 240 Million Yuan
Harbin Gloria Pharma Offloads Entire 42% Stake in Biotech Unit for 240 Million Yuan
Qingdao Pusheng Puli Enterprise Management Center (Limited Partnership) agreed to acquire 42.1204% stake in Guangzhou Gloria Biosciences Co., Ltd. from HARBIN GLORIA PHARMACEUTICALS Co., LTD for CNY240 million.
HARBIN GLORIA PHARMACEUTICALS Co., LTD announced that it expects to receive CNY 300 million in funding
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Consortium of buyers completed the acquisition of a 32.13% stake in Harbin Gloria Pharmaceuticals Co., Ltd from Harbin Gloria Group Co., Ltd.
Harbin Gloria Pharma Swings to Loss in 2022 on Asset Impairment
Harbin Gloria Pharmaceuticals Co., Ltd Announces Executive Appointments
Harbin Gloria Pharmaceuticals Co., Ltd Approves Executive Appointments
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Guangzhou Gloria Biosciences Co., Ltd. announced that it expects to receive CNY 200 million in funding from Harbin Gloria Pharmaceuticals Co., Ltd
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002437
  4. Actualités Harbin Gloria Pharmaceuticals Co., Ltd
  5. Autres langues